Expert consensus published focusing on the study of neurodevelopmental outcomes in pregnancy drug safety studies
Experts from 13 countries and professionally diverse backgrounds took part in the development of a series of recommendations focusing on the importance of including the study of infant neurodevelopment as a core feature of pregnancy drug safety studies. These recommendations outline the core neurodevelopmental outcomes, optimization of methodological approaches and barriers to conducting pregnancy drug safety studies including neurodevelopmental outcomes. The expert consensus is published open access in Frontiers in Pharmacology. See here for more information. PDF also available here.